Scientists hunt for clues in blood and stool to personalize rectal cancer care

NCT ID NCT06831669

First seen Apr 17, 2026 · Last updated May 09, 2026 · Updated 4 times

Summary

This study aims to find out if certain substances in the body (called metabolites) can predict how well rectal cancer responds to chemotherapy and radiation before surgery, and whether severe side effects like radiation proctitis will occur. Researchers will collect blood, urine, tissue, and stool samples from 250 participants before, during, and after treatment. The goal is to develop a test that helps doctors personalize treatment plans.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECTAL NEOPLASM MALIGNANT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Linkou Chang Gung Memorial Hospital

    RECRUITING

    Guishan, Taoyuan, 333, Taiwan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.